For example, skin reactions related to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKI) for non-small cell lung cancer indicated treatment efficacy [26]. Here, EGFR is linked to non-small cell lung carcinoma.